Delivering quality therapy since 1901

Announcements

 

 

Extraordinary announcement2126<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>​The Annual General Meeting of Gedeon Richter Plc. held on 24<sup>th</sup>&#160;April, 2019 approved to pay a dividend of HUF 18,637,486,000 in respect of the 2018 financial year. The details of the dividend payment process were published by the Company on 22<sup>nd</sup>&#160;May, 2019.</p>2019-06-13T22:00:00Z6/14/2019 11:05:47 AM23http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary announcement2124<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>Gedeon Richter Plc. hereby inform its shareholders, that according to the notice of the Maecenas Universitatis Corvini Foundation, the transaction of transferring the 18.637.486 Richter common shares – <em>owned by the Hungarian State and held by Hungarian National Asset Management Inc.</em> <em>(HNMA Inc.)</em> – to the trust management of Maecenas Universitatis Corvini Foundation (hereinafter Foundation) is closed on June 5, 2019.​</p>2019-06-10T22:00:00Z6/11/2019 10:30:15 AM43http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights2112<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-05-30T22:00:00Z5/31/2019 10:40:45 AM53http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Gedeon Richter and Allergan Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression2107<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>​<strong><em>- New Indication Makes VRAYLAR</em></strong><strong><em><sup>®</sup></em></strong><strong><em> First and Only Dopamine and Serotonin Partial Agonist to Treat the Full Spectrum of Bipolar I Symptoms in Manic, Mixed, and Depressive Episodes -</em></strong></p>2019-05-27T22:00:00Z5/28/2019 11:33:45 AM116http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Extraordinary announcement2104<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<span lang="EN-US"><strong>Gedeon Richter Plc. hereby informs its shareholders that, according to the written notice received on May 27, 2019 from the Hungarian National Asset Management Inc. (HNAM Inc.), the Hungarian National Asset Management Inc. started to transfer </strong></span><strong>18,637,486</strong><span lang="EN-US"><strong> Richter common shares – owed by the Hungarian State and held by Hungarian National Asset Management Inc. – to the Maecenas Universitatis Corvini, in line with the regulation of Act XXX of 2019.</strong></span><strong>​</strong><br><br>2019-05-26T22:00:00Z5/27/2019 3:09:58 PM572http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter and Seqirus signed a license agreement for the commercialisation of cariprazine in Australia and New Zealand2102<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>​Gedeon Richter Plc (&quot;Richter&quot;) and Seqirus Pty Ltd (&quot;Seqirus&quot;) today announced the signing of an exclusive license agreement to commercialize cariprazine in Australia and New Zealand.</p>2019-05-23T22:00:00Z6/14/2019 10:53:07 AM127http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Payment of dividends by Chemical Works of Gedeon Richter Plc.2101<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.00000000000<p>​The Chemical Works of Gedeon Richter Plc. (hereinafter&#58; the &quot;<strong>Company</strong>&quot;) would like to inform its shareholders that based on a resolution of the Annual General Meeting held on April 24, 2019, in the case of <strong>common shares</strong>&#58; 100% of the nominal value, that is <strong>HUF 100</strong> per share will be paid as dividends pursuant to paragraph 7.11.1 of the Company's Statutes, in a way that the Company will increase the payment, <em>i.e.</em> distribute the dividend after treasury shares among the shareholders entitled to dividend, in the proportion of their shares. The per share amount of dividend so increased will be established and published by the Company on June 14, 2019 on the website of the Budapest Stock Exchange and of the Company.</p>2019-05-21T22:00:00Z5/22/2019 7:16:43 AM66http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Richter Group Report - 3 Months to March 20192094<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-05-09T22:00:00Z5/10/2019 12:45:34 PM835http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Composition of share capital and voting rights2078<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-04-29T22:00:00Z4/30/2019 2:25:37 PM112http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx
Annual General Meeting 2019 - Proposal, draft resolutions, PoA draft, voting rights2051<img alt="" src="/en-US/PublishingImages/RG%20eng%20logo.jpg" style="BORDER&#58;0px solid;" />2019.000000000002019-04-01T22:00:00Z4/2/2019 7:39:54 AM1978http://rgextend.richter.hu/en-US/investors/announcements/Pages/Forms/AllItems.aspxhtmlFalseaspx